Valuation: CSPC Innovation Pharmaceutical Co., Ltd.

Capitalization 45.77B 6.71B 5.7B 5.22B 4.96B 9.17B 624B 9.36B 61.27B 24.1B 301B 25.19B 24.66B 1,065B P/E ratio 2026 *
51.2x
P/E ratio 2027 * 37.7x
Enterprise value 44.37B 6.51B 5.52B 5.06B 4.81B 8.88B 605B 9.07B 59.38B 23.36B 292B 24.41B 23.9B 1,032B EV / Sales 2026 *
10.7x
EV / Sales 2027 * 8.02x
Free-Float
21.43%
Yield 2026 *
0.94%
Yield 2027 * 1.15%
1 week+0.83%
Current month+3.49%
1 month+3.85%
3 months-16.91%
6 months-25.13%
Current year-8.87%
1 week 30.28
Extreme 30.28
34.86
1 month 27.7
Extreme 27.7
34.9
Current year 27.7
Extreme 27.7
47.92
1 year 27.7
Extreme 27.7
63.31
3 years 9.09
Extreme 9.0917
63.31
5 years 5.36
Extreme 5.3611
63.31
10 years 4.98
Extreme 4.979
63.31
Manager TitleAgeSince
Chief Executive Officer 49 2024-04-21
Director of Finance/CFO 34 2023-04-06
Corporate Secretary 71 -
Director TitleAgeSince
Director/Board Member 52 2015-12-31
Chairman 50 2015-12-31
Director/Board Member 46 2020-09-06
Change 5d. change 1-year change 3-years change Capi.($)
0.00%+0.83%-21.74%+212.50% 6.71B
-5.22%-6.26%+59.24%+92.91% 16.3B
+0.36%+1.64%-2.02%-50.25% 2.73B
+2.45%+9.73%-77.28%-53.83% 1.89B
-0.65%+9.21%+161.73%+17.05% 1.76B
-1.39%-2.26%+18.97%-19.50% 1.61B
-0.85%0.00% - - 1.52B
+6.01%+12.74%-65.39%-65.97% 1.08B
+0.55%+0.38%+10.25%+4.41% 1.04B
-8.68%+24.95%+60.28%+22.88% 984M
Average -0.74%+3.44%+16.00%+17.80% 3.56B
Weighted average by Cap. -2.40%-2.26%+28.82%+77.93%

Financials

2026 *2027 *
Net sales 4.14B 608M 516M 473M 449M 830M 56.54B 848M 5.55B 2.18B 27.28B 2.28B 2.23B 96.4B 5.37B 788M 669M 613M 582M 1.08B 73.32B 1.1B 7.19B 2.83B 35.38B 2.96B 2.9B 125B
Net income 896M 131M 112M 102M 97.09M 179M 12.22B 183M 1.2B 472M 5.9B 493M 483M 20.84B 1.36B 199M 169M 155M 147M 272M 18.53B 278M 1.82B 715M 8.94B 747M 732M 31.6B
Net Debt -1.41B -207M -175M -161M -153M -282M -19.22B -288M -1.89B -742M -9.27B -775M -759M -32.77B -2.69B -395M -335M -307M -292M -539M -36.75B -551M -3.61B -1.42B -17.73B -1.48B -1.45B -62.67B
Logo CSPC Innovation Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of functional ingredients. The Company operates two segments. Functional Ingredients segment mainly provides caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, theophylline, theobromine, pentoxifylline, doxofylline, and biological enzymes. Health Food Products segment mainly provides Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, and others. The Company mainly conducts businesses within the domestic market.
Employees
2,369
Date Price Change Volume
26-04-19 32.87 ¥ 0.00% 15,642,120
26-04-17 32.87 ¥ -3.32% 12,614,140
26-04-16 34.00 ¥ +0.09% 13,007,310
26-04-15 33.97 ¥ +7.98% 22,623,470
26-04-14 31.46 ¥ -4.93% 22,148,290
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
32.87CNY
Average target price
49.80CNY
Spread / Average Target
+51.51%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300765 Stock